Ecto 5'-nucleotidase deficiency in primary hypogammaglobulinaemia. 1978

A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness

The activity of the lymphocyte ectoenzyme 5'-nucleotidase is very low in the majority of patients with primary 'common variable' hypogammaglobulinaemia. In order to test whether this can be explained by lymphocyte subpopulation deficiencies we measured 5'-nucleotidase activity, using both biochemical and histochemical techniques, in purified T and B cells from patients and healthy subjects. Purified B cells from normal subjects have about four times the activity of T cells. This explains why the levels of lymphocyte 5'-nucleotidase activity are at the lower limit of the normal range in patients with X-linked hypogammaglobulinaemia who lack B cells. The low levels in the 'common variable' group can be explained by low activity in their T lymphocytes associated with either low activity in their B cells or depletion of B cells. The finding that inhibition of the enzyme does not interfere with in vitro lymphocyte transformation or immunoglobulin production in normal subjects indicates that the enzyme deficiency is not directly responsible for the hypogammaglobulinaemia. These and other studies suggest that this enzyme appears on lymphocytes at a certain stage of development and that both T and B lymphocytes in some patients with 'common variable' hypogammaglobulinaemia are developmentally immature.

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009708 Nucleotidases A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000361 Agammaglobulinemia An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood. Hypogammaglobulinemia,Agammaglobulinemias,Hypogammaglobulinemias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
January 1998, Ryoikibetsu shokogun shirizu,
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
August 1978, Science (New York, N.Y.),
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
January 1977, Lancet (London, England),
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
October 1991, The Journal of laboratory and clinical medicine,
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
June 2006, Purinergic signalling,
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
March 1974, Science (New York, N.Y.),
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
April 1981, Clinical immunology and immunopathology,
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
September 2015, Infection and immunity,
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
January 1984, Advances in experimental medicine and biology,
A D Webster, and M Rowe, and S M Johnson, and G L Asherson, and A Harkness
January 2023, Frontiers in immunology,
Copied contents to your clipboard!